Cost-effectiveness of an invasive strategy in unstable coronary artery disease. Results from the FRISC II invasive trial | Zendy

Magnus Janzon | Zendy

Open Access

Cost-effectiveness of an invasive strategy in unstable coronary artery disease. Results from the FRISC II invasive trial

Author(s) -

Magnus Janzon

Publication year - 2002

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.2001.2695

Subject(s) - medicine , myocardial infarction , revascularization , coronary artery disease , randomized controlled trial , cardiology , cost effectiveness , clinical endpoint , emergency medicine , surgery , risk analysis (engineering)

The utilization and timing of revascularization in unstable coronary artery disease varies, which could have important consequences for patients and for treatment costs. The FRISC II invasive trial compared an early invasive strategy vs a non-invasive strategy with respect to the composite end-point of death and myocardial infarction as well as costs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research